[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (465)

Search Parameters:
Keywords = cationic lipids

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
27 pages, 5078 KiB  
Review
Boosting Lipofection Efficiency Through Enhanced Membrane Fusion Mechanisms
by Rais V. Pavlov, Sergey A. Akimov, Erdem B. Dashinimaev and Pavel V. Bashkirov
Int. J. Mol. Sci. 2024, 25(24), 13540; https://doi.org/10.3390/ijms252413540 - 18 Dec 2024
Viewed by 132
Abstract
Gene transfection is a fundamental technique in the fields of biological research and therapeutic innovation. Due to their biocompatibility and membrane-mimetic properties, lipid vectors serve as essential tools in transfection. The successful delivery of genetic material into the cytoplasm is contingent upon the [...] Read more.
Gene transfection is a fundamental technique in the fields of biological research and therapeutic innovation. Due to their biocompatibility and membrane-mimetic properties, lipid vectors serve as essential tools in transfection. The successful delivery of genetic material into the cytoplasm is contingent upon the fusion of the vector and cellular membranes, which enables hydrophilic polynucleic acids to traverse the hydrophobic barriers of two intervening membranes. This review examines the critical role of membrane fusion in lipofection efficiency, with a particular focus on the molecular mechanisms that govern lipoplex–membrane interactions. This analysis will examine the key challenges inherent to the fusion process, from achieving initial membrane proximity to facilitating final content release through membrane remodeling. In contrast to viral vectors, which utilize specialized fusion proteins, lipid vectors necessitate a strategic formulation and environmental optimization to enhance their fusogenicity. This review discusses recent advances in vector design and fusion-promoting strategies, emphasizing their potential to improve gene delivery yield. It highlights the importance of understanding lipoplex–membrane fusion mechanisms for developing next-generation delivery systems and emphasizes the need for continued fundamental research to advance lipid-mediated transfection technology. Full article
(This article belongs to the Special Issue Molecular Advances in Liposome-Based Drug Delivery Systems)
Show Figures

Figure 1

Figure 1
<p>Applications of transfection in biological systems. (<b>i</b>) Gene silencing via RNA: transfected siRNA, miRNA, or antisense RNA interfere with mRNA translation, leading to gene silencing (e.g., studying gene function, therapeutic target validation). (<b>ii</b>) mRNA delivery and translation: transfected mRNA is translated into proteins by ribosomes (e.g., protein expression studies, therapeutic protein production). (<b>iii</b>) Gene addition and expression: recombinant transgenic, “alien” DNA introduced into the nucleus undergoes transcription, resulting in mRNA production, which subsequently enters the cytoplasm for translation (e.g., overexpression studies, generating cell lines with specific characteristics). (<b>iv</b>) Stable transfection: alien DNA integrates into the host genome (often mediated by CRISPR/Cas9 systems), enabling long-term expression (e.g., generation of stable cell lines for research and therapeutic applications).</p>
Full article ">Figure 2
<p>Structure and cellular entry mechanisms of lipid-based gene delivery vectors. (<b>a</b>) Structural diversity of lipid-based vectors for gene delivery: (<b>i</b>) Lamellar lipoplex: multilamellar structure with DNA/RNA sandwiched between cationic lipid bilayers. (<b>ii</b>) Hexagonal phase lipoplex: inverted hexagonal phase with nucleic acids enclosed within lipid-lined water channels. (<b>iii</b>) Solid lipid nanoparticle (SLN)/nanostructured lipid carrier (NLC): solid or solid–liquid matrix core surrounded by lipid monolayer. (<b>iv</b>) Nanoghost: cell membrane-derived vesicle retaining native membrane proteins and incorporating genetic cargo. (<b>b</b>) Pathways for cellular entry and genetic cargo delivery. (<b>i</b>) Direct fusion pathway: immediate fusion with plasma membrane; direct cytoplasmic release of genetic material; bypasses endosomal compartmentalization. (<b>ii</b>) Endosomal fusion escape: internalization via endocytosis; fusion with endosomal membrane; controlled release of genetic cargo; membrane merger preserves compartment integrity. (<b>iii</b>) Endosomal rupture pathway: pH-dependent ionization of lipids; osmotic pressure buildup (“proton sponge effect”); endosomal membrane destabilization and rupture; bulk release of vesicle contents.</p>
Full article ">Figure 3
<p>Membrane fusion pathway and associated energy landscape. (<b>a</b>) Sequential stages of membrane fusion. Key feature shown in cross-sectional view. (<b>b</b>) Free energy profile of the fusion cascade.</p>
Full article ">Figure 4
<p>Factors modulating lipid-based vector approaching cellular membrane. (<b>a</b>) Strategies enhancing vector-membrane adhesion. (<b>b</b>) Barriers impeding vector-membrane contact.</p>
Full article ">Figure 5
<p>Sources of hydrophobic defect formation in lipid-based vector shell: (<b>i</b>) solid–liquid crystalline phase coexistence; (<b>ii</b>) lipid packing defects produced by inverted conical lipids; (<b>iii</b>) lipophilic moieties in lipid-based vector formulation.</p>
Full article ">Figure 6
<p>Driving forces of membrane reorganization after its initial contact: (<b>i</b>) the accumulation of inverted-conical lipids (indicated in yellow) that facilitate highly curved temporary structures; (<b>ii</b>) lipid mixing under high chemical potential gradient blue and red arrows indicate the flux direction of lipids from different membranes, shown as red and blue circles.</p>
Full article ">Figure 7
<p>Strategies for enhanced pore formation in hemifusion diaphragm: (<b>i</b>) diaphragm thinning by employment of cationic lipids with shorter acyl chains; (<b>ii</b>) ionizable lipids having cone shape in protonated state. Red and blue circles indicate lipids from two different membranes.</p>
Full article ">
17 pages, 3211 KiB  
Article
Molecular Insights into the Interactions Between Human Serum Albumin and Phospholipid Membranes
by Maciej Przybyłek, Piotr Bełdowski, Damian Ledziński, Zbigniew Lutowski, Adam Mazurkiewicz, Przemysław Raczyński, Andra Dedinaite and Per M. Claesson
Appl. Sci. 2024, 14(24), 11753; https://doi.org/10.3390/app142411753 - 17 Dec 2024
Viewed by 369
Abstract
In this study, molecular dynamics simulations were employed to analyze interactions between phospholipid membranes and human serum albumin (HSA) in the presence of mono- and divalent cations. Two types of membranes, composed of dipalmitoyl phosphatidylcholine (DPPC) and dipalmitoyl phosphatidylethanolamine (DPPE), were utilized. The [...] Read more.
In this study, molecular dynamics simulations were employed to analyze interactions between phospholipid membranes and human serum albumin (HSA) in the presence of mono- and divalent cations. Two types of membranes, composed of dipalmitoyl phosphatidylcholine (DPPC) and dipalmitoyl phosphatidylethanolamine (DPPE), were utilized. The results revealed that both systems exhibited high stability. The DPPE complexes displayed a greater affinity for albumin compared to DPPC. The high stability of the complexes was attributed to a high number of ionic contacts and hydrogen bonds. The presence of mono- and divalent metal cations significantly influenced the membrane’s capacity to bind proteins. However, these effects varied depending on the phospholipid composition of the bilayer. The studies confirmed the relatively low ability of DPPC to bind potassium ions, as previously observed by others. Consequently, the DPPC/HSA/K+ complex was found to be the least stable among the systems studied. While DPPC interactions were limited to HSA domains I and II, DPPE was able to interact with all domains of the protein. Both lipid bilayers exhibited substantial structural changes and characteristic curvature induced by interactions with HSA, which confirms the formation of relatively strong interactions capable of influencing the arrangement of the phospholipids. Full article
(This article belongs to the Section Chemical and Molecular Sciences)
Show Figures

Figure 1

Figure 1
<p>Preferred orientations of HSA concerning the phospholipid bilayer, illustrated by selected snapshots of complexes in the presence of Ca<sup>2+</sup> cations. The membrane is colored pink, HSA domains: I—green, II—yellow, III—red. Panel (<b>A</b>) shows the preferred arrangement of HSA on the DPPC membrane. Panels (<b>B</b>) and (<b>C</b>) present the two possible orientations of HSA with respect to the DPPE membrane.</p>
Full article ">Figure 2
<p>The effect of HSA adsorption on mass profiles of DPPC (<b>A</b>) and DPPE (<b>B</b>) phospholipid bilayers. The z-parameter denotes the distance from the membrane center. Smoothed plots were obtained using a moving average. The mass density values of head group nitrogens were scaled by a factor of 20 due to their low magnitude.</p>
Full article ">Figure 3
<p>Examples of key membrane–HSA interactions are DPPC/HSA (<b>A</b>,<b>B</b>) and DPPE/HSA (<b>C</b>,<b>D</b>). Pink solid lines indicate ionic interactions. Dotted pink—H-bonds. Atoms of lipids are presented in ball-like models and colored in the following fashion: turquoise—carbon, red—oxygen, blue—nitrogen, and yellow—phosphorus. The calcium cation is represented by a pink ball. Large yellow balls indicate magnesium ions. Solid lines with additional side groups in a stick-like model represent the HSA molecule. Its color corresponds to the domains depicted in <a href="#applsci-14-11753-f001" class="html-fig">Figure 1</a>. The panels highlight interactions with specific residues in HSA: Panel A: GLU 321; Panel B: LYS 317, LYS 313, HIS 367, and ASP 365; Panel C: HIS 9, LYS 12, and GLU 16; Panel D: GLU 321, ASP 314, and LYS 317.</p>
Full article ">Figure 4
<p>Bar plot showing the average free binding energy of HSA to the bilayer and its standard deviation for all cases studied. The symbols PC and PE represent the phospholipid membranes formed by DPPC and DPPE, respectively.</p>
Full article ">Figure 5
<p>Root mean square deviation (RMSD) between the Cartesian atom coordinates in the two selections of HSA evolution in time. PC and PE symbols denote the phospholipid membranes formed by DPPC and DPPE, respectively.</p>
Full article ">Figure 6
<p>Bar plot showing the average number and standard deviation of direct ionic interactions for all cases studied. The symbols PC and PE represent the phospholipid membranes formed by DPPC and DPPE, respectively.</p>
Full article ">Figure 7
<p>Bar plot showing the average number of hydrogen bonds and their standard deviation for all cases studied. The symbols PC and PE represent the phospholipid membranes formed by DPPC and DPPE, respectively.</p>
Full article ">
13 pages, 1241 KiB  
Article
Mechanisms of Polymyxin Resistance in Acid-Adapted Enteroinvasive Escherichia coli NCCP 13719 Revealed by Transcriptomics
by Daekeun Hwang and Hyun Jung Kim
Microorganisms 2024, 12(12), 2549; https://doi.org/10.3390/microorganisms12122549 - 11 Dec 2024
Viewed by 465
Abstract
Acid adaptation in Escherichia coli can induce antimicrobial resistance (AMR), posing challenges to global public health. We investigated the effects of acid adaptation on antimicrobial susceptibility, gene expression, zeta potential, and the outer membrane (OM) properties of Escherichia coli NCCP 13719. The acid-adapted [...] Read more.
Acid adaptation in Escherichia coli can induce antimicrobial resistance (AMR), posing challenges to global public health. We investigated the effects of acid adaptation on antimicrobial susceptibility, gene expression, zeta potential, and the outer membrane (OM) properties of Escherichia coli NCCP 13719. The acid-adapted (AA) strain exhibited increased resistance to multiple antimicrobials, with minimum inhibitory concentrations for colistin and polymyxin B increasing eight- and two-fold, respectively. Transcriptomic analysis identified 2225 differentially expressed genes, including upregulated genes associated with resistance to cationic antimicrobial peptides such as arnCTE, marA, and tolC. The upregulation of the arn operon suggests modifications in lipid A of lipopolysaccharides (LPS), reducing the negative charge of the OM and decreasing polymyxin binding affinity. Zeta potential measurements indicated a shift toward a less negative surface charge in the AA strain, which is consistent with LPS modifications. The AA strain also showed decreased OM permeability, which correlated with increased resistance to antimicrobials that penetrate the OM. These mechanisms collectively diminish the efficacy of polymyxins and highlight the potential for environmental factors to drive antimicrobial resistance. In conclusion, the acid adaptation of E. coli NCCP 13719 enhances AMR through changes in gene expression and OM modifications, highlighting the need for careful control of acidic environments during the treatment of medical devices and wastewater from food processing to prevent the emergence of resistant strains. Full article
(This article belongs to the Special Issue Polymyxin Resistance in Gram-Negative Bacteria)
Show Figures

Figure 1

Figure 1
<p>Phenotypic alterations resulting from acid adaptation with rich nutrients. (<b>A</b>) Minimum inhibitory concentration differences of polymyxins between NCCP 13719 control and NCCP 13719 AAR strains. (<b>B</b>) Viable <span class="html-italic">E. coli</span> count under low pH (pH 3.5) post 24 h cultivation in tryptic soy broth at 37 °C. Statistical significance was determined using an unpaired <span class="html-italic">t</span>-test: <span class="html-italic">p</span> &lt; 0.05 (*).</p>
Full article ">Figure 2
<p>Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis for upregulated genes between control vs. acid adaptation with rich nutrients.</p>
Full article ">Figure 3
<p>Genomic arrangement of genes linked to the acid-fitness island and the <span class="html-italic">arn</span> operon. Arrows, scaled to represent gene length and orientation, illustrate the log<sub>2</sub> fold change in upregulation for each gene based on RNA-seq analysis. (<b>A</b>) Acid-fitness island and (<b>B</b>) <span class="html-italic">arn</span> operon.</p>
Full article ">Figure 4
<p>Evaluation of cell surface charge and outer membrane permeability in control and acid-adapted strains. (<b>A</b>) Cell surface charge based on the zeta potential of <span class="html-italic">E. coli</span>. (<b>B</b>) Outer membrane permeability assessed by 1-N-phenylnaphthylamine (NPN) uptake in <span class="html-italic">E. coli</span>. Statistical significance was determined by unpaired <span class="html-italic">t</span>-test: <span class="html-italic">p</span> &lt; 0.01 (**).</p>
Full article ">
23 pages, 2739 KiB  
Article
Computationally Optimized Hemagglutinin Proteins Adjuvanted with Infectimune® Generate Broadly Protective Antibody Responses in Mice and Ferrets
by James D. Allen, Xiaojian Zhang, Jessica M. Medina, Matthew H. Thomas, Amanda Lynch, Ron Nelson, Julia Aguirre and Ted M. Ross
Vaccines 2024, 12(12), 1364; https://doi.org/10.3390/vaccines12121364 - 2 Dec 2024
Viewed by 812
Abstract
Background/Objectives: Standard-of-care influenza vaccines contain antigens that are typically derived from components of wild type (WT) influenza viruses. Often, these antigens elicit strain-specific immune responses and are susceptible to mismatch in seasons where antigenic drift is prevalent. Thanks to advances in viral surveillance [...] Read more.
Background/Objectives: Standard-of-care influenza vaccines contain antigens that are typically derived from components of wild type (WT) influenza viruses. Often, these antigens elicit strain-specific immune responses and are susceptible to mismatch in seasons where antigenic drift is prevalent. Thanks to advances in viral surveillance and sequencing, influenza vaccine antigens can now be optimized using computationally derived methodologies and algorithms to enhance their immunogenicity. Methods: Mice and ferrets that had been previously exposed to historical H1N1 and H3N2 influenza viruses were vaccinated intramuscularly with bivalent mixtures of H1 and H3 recombinant hemagglutinin (rHA) proteins, which were generated using a computationally optimized broadly reactive antigen (COBRA) design methodology. The vaccine antigens were mixed with a cationic lipid nanoparticle adjuvant, Infectimune®, which promotes both humoral and cellular immune responses. Results: Mice and ferrets vaccinated with Infectimune® and COBRA rHAs elicited protective antibody titers against panels of H1N1 and H3N2 influenza viruses isolated over the past 10 years. These animals also had antibodies that neutralized numerous modern H1N1 and H3N2 influenza viruses in vitro. When challenged with the A/Victoria/2570/2019 H1N1 influenza virus, the COBRA rHA vaccinated animals had minimal weight loss, and no detectable virus was present in their respiratory tissues on day 3 post-infection. Conclusions: These results demonstrate that COBRA rHA vaccines formulated with Infectimune® elicit protective antibody responses against influenza strains, which were isolated across periods of time when standard-of-care vaccines were frequently reformulated, thus reducing the need to update vaccines on a nearly annual basis. Full article
(This article belongs to the Section Vaccines against Infectious Diseases)
Show Figures

Figure 1

Figure 1
<p>Mouse H1N1 HAI panel. HAI assays were performed using serum collected from each mouse on day 72 of the study against a panel of H1N1 viruses. The H1N1 panel consisted of 5 viruses isolated from 2009 to 2019 and are listed at the top of each graph (<b>A</b>–<b>E</b>). The Log2 HAI titer is reported on the y-axis. The lower dotted line on the y-axis represents an HAI titer of 1:40, and the upper dotted line represents a titer of 1:80. The vaccine groups are listed on the x-axis of each figure (1–6). (1) 3 μg rHA no adjuvant (blue). (2) Pre-immune mock vaccinated (red). (3) 3 μg rHA + Infectimune<sup>®</sup> (green). (4) 0.6 μg rHA + Infectimune<sup>®</sup> (purple). (5) 0.12 μg rHA + Infectimune<sup>®</sup> (orange). (6) 0.024 μg rHA + Infectimune<sup>®</sup> (black). Statistical values were determined via one-way ANOVA (* = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01, *** = <span class="html-italic">p</span> &lt; 0.001, **** = <span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">Figure 2
<p>Mouse H3N2 HAI panel. HAI assays were performed using serum collected from each mouse on day 72 of the study against a panel of H3N2 viruses. The H3N2 panel consisted of 8 viruses isolated from 2013 to 2020 and are listed at the top of each graph (<b>A</b>–<b>H</b>). The Log2 HAI titer is reported on the y-axis. The lower dotted line on the y-axis represents an HAI titer of 1:40, and the upper dotted line represents a titer of 1:80. The vaccine groups are listed on the x-axis of each figure (1–6). (1) 3 μg rHA no adjuvant (blue). (2) Pre-immune mock vaccinated (red). (3) 3 μg rHA + Infectimune<sup>®</sup> (green). (4) 0.6 μg rHA + Infectimune<sup>®</sup> (purple). (5) 0.12 μg rHA + Infectimune<sup>®</sup> (orange). (6) 0.024 μg rHA + Infectimune<sup>®</sup> (black). Statistical values were determined via one-way ANOVA (* = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01, *** = <span class="html-italic">p</span> &lt; 0.001, **** = <span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">Figure 3
<p>Mouse total IgG and isotype ELISA tiers. ELISA assays detecting the presence of total IgG or different antibody isotypes were performed using serum collected from each mouse on day 72 of the study that was pooled for each group. Plates were coated with either Y2 (<b>A</b>–<b>C</b>) H1 or NG2 (<b>D</b>–<b>F</b>) H3 rHA and probed with different secondary antibodies specific for either total IgG (<b>A</b>,<b>D</b>), IgG1 (<b>B</b>,<b>E</b>) or IgG2a (<b>C</b>,<b>F</b>). Endpoint dilution titers are plotted on the y-axis, and the vaccine groups are listed on the x-axis of each figure (1–6). (1) 3 μg rHA no adjuvant (blue). (2) Pre-immune mock vaccinated (red). (3) 3 μg rHA + Infectimune<sup>®</sup> (green). (4) 0.6 μg rHA + Infectimune<sup>®</sup> (purple). (5) 0.12 μg rHA + Infectimune<sup>®</sup> (orange). (6) 0.024 μg rHA + Infectimune<sup>®</sup> (black). The ratio of the IgG1:IgG2a endpoint dilution titers were determined for the H1-specific anti-Y2 antibodies (<b>G</b>) and H3 specific anti-NG2 antibodies (<b>H</b>) for each group of vaccinated mice.</p>
Full article ">Figure 4
<p>Mouse challenge weight loss and viral plaque titers. Mice were infected with A/Victoria/2570/2019 H1N1 virus on day 86 of the study. The mice were monitored for weight loss and survival (% listed next to each vaccine group) (<b>A</b>). On day 3 following infection, lungs were harvested from 3 mice in each group, which were assessed for viral titers via plaque assay (<b>B</b>). The different groups are represented in each figure by different colors: 3 μg rHA (blue), pre-immune mock vaccinated (red). 3 μg rHA + Infectimune<sup>®</sup> (green). 0.6 μg rHA + Infectimune<sup>®</sup> (purple). (5) 0.12 μg rHA + Infectimune<sup>®</sup> (orange). (6) 0.024 μg rHA + Infectimune<sup>®</sup> (black). Statistical values were determined via one-way ANOVA (* = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 5
<p>Ferret H1N1 and H3N2 HAI panel. HAI assays were performed using serum collected from each ferret on day 102 of the study against a panel of H1N1 (<b>A</b>–<b>C</b>) and H3N2 (<b>D</b>–<b>F</b>) viruses. The H1N1 panel consisted of 5 viruses isolated from 2009 to 2019, and the H3N2 panel consisted of 8 viruses isolated from 2013 to 2020. The vaccine groups are listed at the top of each figure. The Log2 HAI titer is reported on the y-axis. The lower dotted line on the y-axis represents an HAI titer of 1:40, and the upper dotted line represents a titer of 1:80. The viruses in each panel are listed on the x-axis of each figure. Statistical values were determined via one-way ANOVA (* = <span class="html-italic">p</span> &lt; 0.05, ** = <span class="html-italic">p</span> &lt; 0.01, *** = <span class="html-italic">p</span> &lt; 0.001, **** = <span class="html-italic">p</span> &lt; 0.0001).</p>
Full article ">Figure 6
<p>Ferret H1N1 and H3N2 Microneutralization panel. Microneutralization assays were performed using pooled serum collected from each group of ferrets on day 102 of the study against a panel of H1N1 and H3N2 viruses. The H1N1 panel consisted of 5 viruses isolated from 2009 to 2019 (<b>A</b>–<b>E</b>), and the H3N2 panel consisted of 5 viruses isolated from 2016 to 2020 (<b>F</b>–<b>J</b>). The Log2 50% neutralization titers are listed on the y-axis of each figure. The vaccine groups are listed on the x-axis of each figure. The virus used in each assay is listed at the top of each figure. Data from each group are represented by different colors: Y2 + NG2 (blue), Mich/15 + Sing/16 (red), and pre-immune mock vaccinated (black).</p>
Full article ">Figure 7
<p>Ferret challenge weight loss and viral plaque titers. The vaccinated pre-immune ferrets were infected with A/Victoria/2570/2019 H1N1 virus on day 116 of the study and were tracked for weight loss for 14 days (<b>A</b>). Weight loss values were reported as percent original body weight based on the weight of each animal on day 116 and are listed on the y-axis. On day 3 following infection, nasal wash samples were collected from the ferrets in each group, which were assessed for viral titers via viral plaque assay (<b>B</b>). Viral titers of the nasal wash samples are reported as PFU/mL on the y-axis. Data from each group are represented by different colors: Y2 + NG2 (blue), Mich/15 + Sing/16 (red), and pre-immune mock vaccinated (black).</p>
Full article ">
26 pages, 6769 KiB  
Review
Effect of Lipid Nanoparticle Physico-Chemical Properties and Composition on Their Interaction with the Immune System
by Laura Catenacci, Rachele Rossi, Francesca Sechi, Daniela Buonocore, Milena Sorrenti, Sara Perteghella, Marco Peviani and Maria Cristina Bonferoni
Pharmaceutics 2024, 16(12), 1521; https://doi.org/10.3390/pharmaceutics16121521 - 26 Nov 2024
Viewed by 1036
Abstract
Lipid nanoparticles (LNPs) have shown promise as a delivery system for nucleic acid-based therapeutics, including DNA, siRNA, and mRNA vaccines. The immune system plays a critical role in the response to these nanocarriers, with innate immune cells initiating an early response and adaptive [...] Read more.
Lipid nanoparticles (LNPs) have shown promise as a delivery system for nucleic acid-based therapeutics, including DNA, siRNA, and mRNA vaccines. The immune system plays a critical role in the response to these nanocarriers, with innate immune cells initiating an early response and adaptive immune cells mediating a more specific reaction, sometimes leading to potential adverse effects. Recent studies have shown that the innate immune response to LNPs is mediated by Toll-like receptors (TLRs) and other pattern recognition receptors (PRRs), which recognize the lipid components of the nanoparticles. This recognition can trigger the activation of inflammatory pathways and the production of cytokines and chemokines, leading to potential adverse effects such as fever, inflammation, and pain at the injection site. On the other hand, the adaptive immune response to LNPs appears to be primarily directed against the protein encoded by the mRNA cargo, with little evidence of an ongoing adaptive immune response to the components of the LNP itself. Understanding the relationship between LNPs and the immune system is critical for the development of safe and effective nucleic acid-based delivery systems. In fact, targeting the immune system is essential to develop effective vaccines, as well as therapies against cancer or infections. There is a lack of research in the literature that has systematically studied the factors that influence the interaction between LNPs and the immune system and further research is needed to better elucidate the mechanisms underlying the immune response to LNPs. In this review, we discuss LNPs’ composition, physico-chemical properties, such as size, shape, and surface charge, and the protein corona formation which can affect the reactivity of the immune system, thus providing a guide for the research on new formulations that could gain a favorable efficacy/safety profile. Full article
(This article belongs to the Special Issue Advances in Nanotechnology-Based Drug Delivery Systems)
Show Figures

Figure 1

Figure 1
<p>Even slight modifications can change the properties of an LNP. (<b>A</b>) By modifying the molar ratio of PEG or the preparation parameters, it is possible to change the LNP size. (<b>B</b>) The surface charge of the LNP can be modified by replacing or adding phospholipids to a charged lipid. (<b>C</b>) Different PEG–lipid conjugates can be obtained, such as modifying the PEG molecular weight, to influence LNP size, zeta potential, and stability. (<b>D</b>) Adjuvants can be added to the formulation to enhance the immune reaction for LNP-based mRNA vaccines. (<b>E</b>) There are several methods for administering LNPs, including intravenous (IV), intramuscular (IM), intradermal (ID), subcutaneous (SC), and intranasal (IN). An appropriate route of administration must be determined based on an understanding of the anatomy of the inoculation site and the induced immune action. Reprinted with permission from [<a href="#B4-pharmaceutics-16-01521" class="html-bibr">4</a>].</p>
Full article ">Figure 2
<p>Cryo-TEM image of LNP prepared in the presence of siRNA: LNPs exhibit stacked bilayer structure (<b>left</b>); representative image of LNP structure (<b>right</b>). Reprinted with permission from [<a href="#B21-pharmaceutics-16-01521" class="html-bibr">21</a>]. Copyright 2018 American Chemical Society.</p>
Full article ">Figure 3
<p>Schematic illustration of biological properties affected by the LNP physico-chemical properties.</p>
Full article ">Figure 4
<p>Illustration of LNPs structure and components. Reprinted with permission [<a href="#B24-pharmaceutics-16-01521" class="html-bibr">24</a>].</p>
Full article ">Figure 5
<p>Schematic representation of cationic and ionizable lipids and their components (headgroup, linker, and tail). Reprinted with permission from [<a href="#B30-pharmaceutics-16-01521" class="html-bibr">30</a>]. Copyright 2022 American Chemical Society.</p>
Full article ">Figure 6
<p>The illustration underscores the primary challenges and drawbacks associated with LNP vaccines. One significant opportunity lies in the ability to modify the protein corona composition, which can help mitigate off-target accumulation and enhance the interaction of LNPs with antigen-presenting cells and dendritic cells. This, in turn, has the potential to significantly improve vaccine efficacy. Reprinted with permission [<a href="#B38-pharmaceutics-16-01521" class="html-bibr">38</a>].</p>
Full article ">
11 pages, 1657 KiB  
Article
Improved Sensitivity of a Taste Sensor Composed of Trimellitic Acids for Sweetness
by Tatsukichi Watanabe, Sojiro Kumura, Shunsuke Kimura and Kiyoshi Toko
Molecules 2024, 29(23), 5573; https://doi.org/10.3390/molecules29235573 - 25 Nov 2024
Viewed by 462
Abstract
Currently, lipid/polymer membranes are used in taste sensors to quantify food taste. This research aims to improve sweetness sensors by more selectively detecting uncharged sweetening substances, which have difficulty obtaining a potentiometric response. Lipid/polymer membranes with varying amounts of tetradodecylammonium bromide (TDAB) and [...] Read more.
Currently, lipid/polymer membranes are used in taste sensors to quantify food taste. This research aims to improve sweetness sensors by more selectively detecting uncharged sweetening substances, which have difficulty obtaining a potentiometric response. Lipid/polymer membranes with varying amounts of tetradodecylammonium bromide (TDAB) and 1,2,4-benzene tricarboxylic acid (trimellitic acid) were prepared. The carboxyl groups of trimellitic acid bind metal cations, and the sweetness intensity is estimated by measuring the potential change, as a sensor response, when these cations are complexed with sugars. This research showed that the potential of a sensor using the membrane with enough trimellitic acid in a sucrose solution remained constant, regardless of TDAB amounts, but the potential in the tasteless, so-called reference solution, depended on TDAB. By optimizing the content of TDAB and trimellitic acid, a sensor response of −100 mV was achieved, which is over 20% more sensitive than a previous sensor. This sensor also demonstrated increased selectivity to sweetness, with similar interference from other tastes (saltiness, sourness, umami, and bitterness) compared to previous sensors. As a result, the sensitivity to sweetness was successfully improved. This result contributes to the development of novel sensors, further reducing the burden on humans in quality control and product development. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Reference potential for sensors with 0.1, 0.3, 1.0, 3.0, and 10 mg TDAB and 0, 30, 56, 100, 130, 170, 220, and 300 mg trimellitic acid, respectively. (<b>b</b>) Relative value in 1000 mM sucrose solution for sensors with 0.1, 0.3, 1.0, 3.0, and 10 mg TDAB and 30, 56, 100, 130, 170, 220, and 300 mg trimellitic acid, respectively. The error bar indicates the standard deviations (SD) of the data, <span class="html-italic">n</span> = 4 (electrode) × 3 (rotation) = 12 values.</p>
Full article ">Figure 2
<p>Sensor potential in 1000 mM sucrose solution for sensors with 0.3, 1.0, and 3.0 mg TDAB and 30, 56, 100, 130, 170, 220, and 300 mg trimellitic acid, respectively. The error bar indicates the SD of the data, <span class="html-italic">n</span> = 4 (electrode) × 3 (rotation) = 12 values.</p>
Full article ">Figure 3
<p>Relative value in 1000 mM sucrose solution for sensors with 100 mg trimellitic acid and 0.1, 0.3, 1.0, 3.0, 4.0, 5.0, and 10 mg TDAB. The error bar indicates the SD of the data, <span class="html-italic">n</span> = 4 (electrode) × 3 (rotation) = 12 values.</p>
Full article ">Figure 4
<p>Comparison of responses in five basic taste samples for the sensor developed in this research (4 mg TDAB and 100 mg trimellitic acid) and the sensor (1 mg TDAB and 100 mg trimellitic acid) presented in previous research [<a href="#B29-molecules-29-05573" class="html-bibr">29</a>,<a href="#B32-molecules-29-05573" class="html-bibr">32</a>]. In previous research (red) [<a href="#B29-molecules-29-05573" class="html-bibr">29</a>], the conditioning solution during the measurement contained potassium ions, and in previous research (blue) [<a href="#B32-molecules-29-05573" class="html-bibr">32</a>], the conditioning solution contained sodium ions.</p>
Full article ">Figure 5
<p>Structure of membrane components (<b>a</b>) TDAB, (<b>b</b>) DOPP, and (<b>c</b>) trimellitic acid.</p>
Full article ">Figure 6
<p>Structure of taste sensor electrode and reference electrode.</p>
Full article ">Figure 7
<p>Measurement cycle and state of binding of sodium ions to trimellitic acid, a modifier, on the surface of the sensor membrane in the conditioning solution, reference solution, and sample solution.</p>
Full article ">
22 pages, 6119 KiB  
Article
Cationic Lipid Derived from a Basic Amino Acid: Design and Synthesis
by Diana M. Bravo-Estupiñan, Mariela Montaño-Samaniego, Rodrigo A. Mora-Rodríguez and Miguel Ibáñez-Hernández
Appl. Sci. 2024, 14(23), 10892; https://doi.org/10.3390/app142310892 - 25 Nov 2024
Viewed by 579
Abstract
One of the major challenges in gene therapy is the efficient and safe introduction of nucleic acids into eukaryotic cells. This process requires overcoming various biological barriers and navigating complex pathways to reach target cells and achieve their biological function. To address this [...] Read more.
One of the major challenges in gene therapy is the efficient and safe introduction of nucleic acids into eukaryotic cells. This process requires overcoming various biological barriers and navigating complex pathways to reach target cells and achieve their biological function. To address this obstacle, numerous transfection methods have been developed, including physical techniques and the use of genetic vectors, both viral and non-viral. However, to date, no transfection method is 100% safe and efficient. Within the spectrum of non-viral genetic vectors, cationic liposomes formed by cationic lipids stand out for their ability to protect and deliver therapeutic NA. These liposomes offer greater biocompatibility and lower immunogenicity compared to viral vectors, although they still do not match the efficiency of viral delivery systems. Consequently, ongoing research focuses on synthesizing a wide variety of cationic lipids in the search for compounds that provide high transfection efficiency with minimal cytotoxicity. This study aimed to design and synthesize a novel cationic lipid (CholCadLys) derived from natural cellular molecules for transferring genetic material to eukaryotic cells. The lipid was synthesized using cholesteryl chloroformate for the hydrophobic region, cadaverine as a linker, and lysine for the polar region, connected by carbamate and amide bonds, respectively. Identification was confirmed through thin-layer chromatography, purification through preparative chromatography, and characterization via infrared spectroscopy and mass spectrometry. The synthesis yielded a 60% success rate, with stable nanoliposomes averaging 76 nm in diameter. Liposomes were formed using this CL and commercial neutral lipids, characterized by transmission electron microscopy and Nanoparticle Tracking Analysis. These liposomes, combined with plasmid DNA, formed lipoplexes used to transfect Hek-293 FT cells, achieving up to 40% transfection efficiency without cytotoxicity in the mixture of CholCadLys and CholCad. This novel CL demonstrates potential as an efficient, safe, and cost-effective gene transfer system, facilitating further development in gene therapy. Full article
Show Figures

Figure 1

Figure 1
<p>Molecular structure of synthesized CholCadLys lipid. The formation of a carbamate bond between cholesteryl chloroformate and cadaverine and an amide bond between cadaverine and lysine is observed. UIPAC name: 10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl (5-(2,6-diaminohexanamido)pentyl) carbamate.</p>
Full article ">Figure 2
<p>(<b>I</b>) Identification of the unpurified synthesized CholCadLys lipid. The raw material was placed in the chromatogram (1: cholesteryl chloroformate; 2: a mixture of raw materials, reaction intermediates, and the unpurified synthesized cationic lipid can be observed; and 3: L-lysine). Chromatogram (<b>A</b>) of each lipid was revealed with ninhydrin (presence of free amino groups), while chromatogram (<b>B</b>) was revealed with sulfuric acid (presence of organic matter). (<b>II</b>) Identification of the purified synthesized CholCadLys lipid. The raw material was placed in the chromatogram (1: cholesteryl chloroformate; 2: purified synthesized lipid; and 3: L-lysine). Chromatogram (<b>A</b>) of each lipid was revealed with ninhydrin (presence of free amino groups), while chromatogram (<b>B</b>) was revealed with sulfuric acid (presence of organic matter).</p>
Full article ">Figure 3
<p>The infrared spectrum of the synthesized CholCadLys lipid. The signal at 1688.59–1641.63 cm<sup>−1</sup> corresponds to the C=O stretching of the carbonyl of the amide bond. The signal at 3298.84 cm<sup>−1</sup> corresponds to the elongation of the -NH groups, the signals at 2918.33 cm<sup>−1</sup> and 2849.56 cm<sup>−1</sup> correspond to the C-H elongations of the methyl and methylene groups of the hydrocarbon chains, and the signals 1451–1413 cm<sup>−1</sup> correspond to the CH<sub>3</sub> elongations.</p>
Full article ">Figure 4
<p>The mass spectrum of the CholCadLys lipid. A signal with an exact mass of 643.5439 Da, corresponding to the CholCadLys lipid, was observed.</p>
Full article ">Figure 5
<p>A genetic map of the pIRES2-EGFP plasmid. The plasmid components and specific restriction enzyme cleavage sites are depicted.</p>
Full article ">Figure 6
<p>An electropherogram of the purified pIRES2-EGFP plasmid integrity. Lane 1: Quick-Load 1Kb DNA Ladder molecular size marker; Lane 2: pIRES2-EGFP control pDNA; Lanes 3–4: 1 and 2 μL of plasmid DNA extraction and purification.</p>
Full article ">Figure 7
<p>Electropherograms of lipoplexes formed with CholCadLys and helper lipids at different <span class="html-italic">w</span>/<span class="html-italic">w</span> ratios (1 μg total lipids/different amounts of pDNA). (<b>A</b>) CholCadLys–DOPE 2:1; (<b>B</b>) CholCadLys–CholCad 1:2; (<b>C</b>) CholCadLys–CholCad 2:1; (<b>D</b>) CholCadLys–CholCad–DOPE 1:1:2; (<b>E</b>) CholCadLys–CholCad–DOPE 2:1:1. 1. pDNA control. 2. Ratio of 1:0.66 μg DNA. 3. Ratio of 1:0.40 μg DNA. 4. Ratio of 1:0.28 μg DNA. 5. Ratio of 1:0.22 μg DNA. 6. Ratio of 1:0.18 μg DNA.</p>
Full article ">Figure 8
<p>TEM micrographs of liposomes and lipoplexes (total lipid/pDNA ratio of 1:0.4). (<b>A</b>) Liposomes formed with CholCadLys–cholesterol at a molar ratio of 1:1. (<b>B</b>) Lipoplexes formed with CholCadLys–cholesterol at a molar ratio of 1:1. (<b>C</b>) Liposomes formed with CholCadLys–cholesterol at a molar ratio of 2:1. (<b>D</b>) Lipoplexes formed with CholCadLys–cholesterol at a molar ratio of 2:1. (<b>E</b>) Liposomes formed with CholCadLys–DOPE at a molar ratio of 1:1. (<b>F</b>) Lipoplexes formed with CholCadLys–DOPE at a molar ratio of 1:1. (<b>G</b>) Liposomes formed with CholCadLys–DOPE at a molar ratio of 1:2. (<b>H</b>) Lipoplexes formed with CholCadLys–DOPE at a molar ratio of 1:2.</p>
Full article ">Figure 9
<p>Transfection efficiency in Hek-293 FT, defined as the percentage of GFP-positive cells detected by fluorescence microscopy.</p>
Full article ">Figure 10
<p>Transfection in Hek-293 FT Cell Line. Different lipoplex mixtures were prepared using the synthesized lipid and a helper lipid in various ratios. (<b>A</b>) Untransfected control cells; (<b>B</b>) CholCadLys; (<b>C</b>) CholCadLys–cholesterol 1:1; (<b>D</b>) CholCadLys–cholesterol 2:1; (<b>E</b>) CholCad–DOPE 1:1; (<b>F</b>) CholCad–DOPE 1:2; (<b>G</b>) CholCad–DOPE 2:1; (<b>H</b>) CholCad; (<b>I</b>) CholCadLys–DOPE 1:1; (<b>J</b>) CholCadLys–DOPE 1:2; (<b>K</b>) CholCadLys–CholCad 1:2; (<b>L</b>) CholCadLys–CholCad 2:1; (<b>M</b>) CholCadLys–CholCad–DOPE 1:1:2; (<b>N</b>) CholCadLys–CholCad–DOPE 2:1:1; (<b>O</b>) Lipofectamine 0.5 μg–0.400 μg DNA.</p>
Full article ">Figure 11
<p>Viability effect on Hek-293 FT cell line. (<b>A</b>) Negative control cells; (<b>B</b>) lipoplexes formed with cholesterol as a helper lipid; (<b>C</b>) lipoplexes formed with DOPE as a helper lipid; (<b>D</b>) lipoplexes formed with CholCadLys–CholCad–DOPE 1:1:2; (<b>E</b>) lipoplexes formed with CholCadLys–CholCad–DOPE 2:1:1; (<b>F</b>) Lipofectamine 0.5 μg.</p>
Full article ">
13 pages, 1477 KiB  
Article
Ginsenoside-Enriched Extract from Black Ginseng Anti-Fatigue Effects by Improving Antioxidant Capacity and Mitochondrial Function
by Shunji Ge, Jiating Li, Xueyue Tai, Kuo Wang, Liyan Huang, Weixin Su, Guoqi Zhang, Bao Zhong and Fenglin Li
Life 2024, 14(11), 1467; https://doi.org/10.3390/life14111467 - 12 Nov 2024
Viewed by 717
Abstract
In this study, we investigated the anti-fatigue effects of black ginseng ginsenosides using exercise performance tests, serum analyses, and gene expression profiling. No significant differences in dietary intake or body weight were observed between groups. The low-dose black ginseng (LBG) group showed no [...] Read more.
In this study, we investigated the anti-fatigue effects of black ginseng ginsenosides using exercise performance tests, serum analyses, and gene expression profiling. No significant differences in dietary intake or body weight were observed between groups. The low-dose black ginseng (LBG) group showed no significant improvements in swimming and rotating rod tests. In contrast, the medium (MBG)- and high-dose (HBG) groups showed notable increases in swimming time and significant improvements in the rotating rod test. All treatment groups exhibited longer running times, particularly the HBG group. Serum analysis revealed increased muscle and hepatic glycogen, catalase, and lactate dehydrogenase levels in the MBG and HBG groups, whereas lactate, lipid peroxide, and superoxide dismutase levels were decreased. Additionally, gene expression analysis showed significant upregulation of key antioxidant and mitochondrial function genes, including those encoding cationic amino acid transporter 2, stearoyl-CoA desaturase-2, nuclear respiratory factor 1, nuclear factor erythroid 2-related factor 2, mitochondrial transcription factor A, cytochrome c oxidase II, and NADH–ubiquinone oxidoreductase core subunit 1, particularly in the HBG group, indicating enhanced antioxidant capacity and improved mitochondrial function. These findings suggested that black ginseng ginsenosides effectively mitigated fatigue. Full article
Show Figures

Figure 1

Figure 1
<p>High-performance liquid chromatography profiles. (<b>A</b>) High-performance liquid chromatography profiles of ginsenoside standards; (<b>B</b>) high-performance liquid chromatography profiles of ginsenosides in black ginseng.</p>
Full article ">Figure 2
<p>The effect of black ginseng ginsenoside treatment on the tissue and serum markers of fatigue in mice. (<b>A</b>) Muscle glycogen, (<b>B</b>) hepatic glycogen, (<b>C</b>) lactate, (<b>D</b>) lactate dehydrogenase, (<b>E</b>) catalase, (<b>F</b>) lipid peroxides, and (<b>G</b>) total superoxide dismutase. The animals were gavaged daily for 21 d with either a low—(LBG group, 300 mg/kg), medium—(MBG group, 400 mg/kg), or high—(HBG group, 500 mg/kg) dose of black ginseng ginsenoside extract. Following an exercise challenge involving treadmill running, swimming, and rotating rod exercises, the mice were killed, and serum samples were obtained. The results are the mean ± standard deviation. The values bearing different superscripted letters are significantly different.</p>
Full article ">Figure 3
<p>The expression of hepatic genes involved in fatigue determined by real-time PCR. The relative mRNA levels are presented as the mean ± standard deviation. The values bearing different superscripted letters are significantly different. (<b>A</b>) <span class="html-italic">CAT-2</span>, cationic amino acid transporter 2; (<b>B</b>) Scd-2, stearoyl-CoA desaturase-2; (<b>C</b>) <span class="html-italic">NRF1</span>, nuclear respiratory factor 1; (<b>D</b>) <span class="html-italic">NRE2L2</span>, nuclear factor erythroid 2–related factor 2; (<b>E</b>) <span class="html-italic">TFAM</span>, mitochondrial transcription factor A; (<b>F</b>) <span class="html-italic">MtCOX2</span>, cytochrome c oxidase II; and (<b>G</b>) <span class="html-italic">MtND1</span>, mitochondrial NADH–ubiquinone oxidoreductase core subunit 1.</p>
Full article ">
13 pages, 3663 KiB  
Article
Lipid Nanoparticle-Mediated Liver-Specific Gene Therapy for Hemophilia B
by Brijesh Lohchania, Porkizhi Arjunan, Gokulnath Mahalingam, Abinaya Dandapani, Pankaj Taneja and Srujan Marepally
Pharmaceutics 2024, 16(11), 1427; https://doi.org/10.3390/pharmaceutics16111427 - 9 Nov 2024
Viewed by 947
Abstract
Background/Objectives: Hemophilia B is a hereditary bleeding disorder due to the production of liver malfunctional factor IX (FIX). Gene therapy with viral vectors offers a cure. However, applications are limited due to pre-existing antibodies, eligibility for children under 12 years [...] Read more.
Background/Objectives: Hemophilia B is a hereditary bleeding disorder due to the production of liver malfunctional factor IX (FIX). Gene therapy with viral vectors offers a cure. However, applications are limited due to pre-existing antibodies, eligibility for children under 12 years of age, hepatotoxicity, and excessive costs. Lipid nanoparticles are a potential alternative owing to their biocompatibility, scalability, and non-immunogenicity. However, their therapeutic applications are still elusive due to the poor transfection efficiencies in delivering plasmid DNA into primary cells and target organs in vivo. To develop efficient liver-targeted lipid nanoparticles, we explored galactosylated lipids to target asialoglycoprotein receptors (ASGPRs) abundantly expressed on hepatocytes. Methods: We developed 12 novel liposomal formulations varying the galactose lipid Gal-LNC 5, cationic lipid MeOH16, DOPE, and cholesterol. We evaluated their physicochemical properties, toxicity profiles, and transfection efficiencies in hepatic cell lines. Among the formulations, Gal-LNC 5 could efficiently transfect the reporter plasmid eGFP in hepatic cell lines and specifically distribute into the liver in vivo. Toward developing functional factor IX, we cloned Padua mutant FIX-L in a CpG-free backbone to enhance the expression and duration. Results: We demonstrated superior expression of FIX with our galactosylated lipid nanoparticle system. Conclusions: The current research presents a specialized lipid nanoparticle system viz. Gal-LNC which is a specialized lipid nanoparticle system for liver-targeted gene therapy in hemophilia B patients that has potential for clinical use. The Gal-LNC successfully delivers a CpG-free Padua FIX gene to liver cells, producing therapeutically relevant levels of FIX protein. Among its benefits are the ideal qualities of stability, targeting the liver specifically, and maximizing efficiency of transfection. Optimization of liver-targeting lipid nanoparticle systems and function FIX plasmids will pave the way for novel lipid nanoparticle-based gene therapy products for hemophilia B and other monogenic liver disorders. Full article
(This article belongs to the Section Gene and Cell Therapy)
Show Figures

Figure 1

Figure 1
<p>LNC and Gal-LNC characterizations. (<b>a</b>) Lipid structures of LNC and Gal-LNC, (<b>b</b>) size, (<b>c</b>) zeta, and (<b>d</b>) polydispersity indexes of LNC and Gal-LNC (n = 3).</p>
Full article ">Figure 2
<p>Liposomes complexation study of pDNA. (<b>a</b>) Electrophoretic mobility retardation assay of naked pDNA, LNC, and Gal-LNC with charge ratios (1:1, 2:1, 4:1, and 8:1); (<b>b</b>) Heparin displacement assay of naked pDNA, LNC and Gal-LNC lipoplex in the presence of heparin; (<b>c</b>) DNase Sensitivity assay for LNC and Gal-LNC in the presence of DNase I enzyme.</p>
Full article ">Figure 3
<p>In vitro compatibility of LNPs. (<b>a</b>) Uptake assay of LNC and Gal-LNC 5, % of uptake analyzed by Flow cytometry, (<b>b</b>) Cytotoxicity assay of LNC and Gal-LNC (n = 3).</p>
Full article ">Figure 4
<p>Screening of liposome efficiency by transfecting pDNA. (<b>a</b>) Transfections of LNC and Gal-LNC screening in HEK293T with pDNA, the qualitative analysis by imaging; (<b>b</b>) Quantitative analysis by flow cytometry (n = 3), (<b>c</b>) Transfections of LNC and Gal-LNC screening in HepG2 with pDNA, the qualitative analysis by imaging; (<b>d</b>) Quantitative analysis by flow cytometry % of eGFP cells represents the overall percentage of positive cells.</p>
Full article ">Figure 5
<p>FIX-L pDNA construct and expression. (<b>a</b>) FIX-L gene construct in CpG-free sequence backbone; (<b>b</b>) The clone was confirmed by sequencing and restriction digestion (n = 4); (<b>c</b>) The plasmid expression in non-hepatic cell line HEK293T by qPCR (n = 2); (<b>d</b>) The plasmid expression in non-hepatic cell line HepG2 by qPCR (n = 2) (<b>e</b>) The FIX-L pDNA protein expression was confirmed by Western blot in HEK293T cells; (<b>f</b>) The FIX-L pDNA protein expression was confirmed by Western blot in HepG2 cells; (<b>g</b>) The bands were quantified by ImageJ software v. 3.0.1.14—HEK293T (refer c) (n = 2) (<b>h</b>) The bands were quantified by ImageJ software—HepG2 (refer f) (n = 2) (<b>i</b>) Western blot analysis for FIX-L pDNA in HEK293T cells expression of media supernatant (<b>j</b>) The bands were quantified by ImageJ software (n = 2). ns—non-significant; * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01; *** <span class="html-italic">p</span> &lt; 0.001. UT—untreated; LF—Lipofectamine 3000.</p>
Full article ">Figure 6
<p>Biodistribution of 16 cyGAL5. (<b>a</b>) Control mice; (<b>b</b>) Localization of LNC to the liver and other organs; (<b>c</b>) Uptake of Gal-LNC 5 to liver; (<b>d</b>) Epifluorescence of Gal-LNC 5 (n = 3) * <span class="html-italic">p</span> &lt; 0.01 ** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">
31 pages, 3958 KiB  
Review
Emerging Cationic Nanovaccines
by Ana Maria Carmona-Ribeiro and Yunys Pérez-Betancourt
Pharmaceutics 2024, 16(11), 1362; https://doi.org/10.3390/pharmaceutics16111362 - 25 Oct 2024
Viewed by 923
Abstract
Cationic vaccines of nanometric sizes can directly perform the delivery of antigen(s) and immunomodulator(s) to dendritic cells in the lymph nodes. The positively charged nanovaccines are taken up by antigen-presenting cells (APCs) of the lymphatic system often originating the cellular immunological defense required [...] Read more.
Cationic vaccines of nanometric sizes can directly perform the delivery of antigen(s) and immunomodulator(s) to dendritic cells in the lymph nodes. The positively charged nanovaccines are taken up by antigen-presenting cells (APCs) of the lymphatic system often originating the cellular immunological defense required to fight intracellular microbial infections and the proliferation of cancers. Cationic molecules imparting the positive charges to nanovaccines exhibit a dose-dependent toxicity which needs to be systematically addressed. Against the coronavirus, mRNA cationic nanovaccines evolved rapidly. Nowadays cationic nanovaccines have been formulated against several infections with the advantage of cationic compounds granting protection of nucleic acids in vivo against biodegradation by nucleases. Up to the threshold concentration of cationic molecules for nanovaccine delivery, cationic nanovaccines perform well eliciting the desired Th 1 improved immune response in the absence of cytotoxicity. A second strategy in the literature involves dilution of cationic components in biocompatible polymeric matrixes. Polymeric nanoparticles incorporating cationic molecules at reduced concentrations for the cationic component often result in an absence of toxic effects. The progress in vaccinology against cancer involves in situ designs for cationic nanovaccines. The lysis of transformed cancer cells releases several tumoral antigens, which in the presence of cationic nanoadjuvants can be systemically presented for the prevention of metastatic cancer. In addition, these local cationic nanovaccines allow immunotherapeutic tumor treatment. Full article
(This article belongs to the Special Issue Applications of Nanomaterials in Immunotherapies)
Show Figures

Figure 1

Figure 1
<p>Immune responses Th-1 and/or Th-2 elicited by cationic nanostructures carrying ovalbumin (OVA) depend on affinity between OVA antigen and adjuvant. Molecules used to build the nanostructures were: the synthetic lipid dioctadecyl dimethyl ammonium bromide (DODAB), the polyelectrolyte PDDA and the biocompatible polymer poly (methyl methacrylate) (PMMA). Reproduced from reference [<a href="#B14-pharmaceutics-16-01362" class="html-bibr">14</a>,<a href="#B16-pharmaceutics-16-01362" class="html-bibr">16</a>].</p>
Full article ">Figure 2
<p>Intracellular routes followed by cationic nanoparticles (NPs) acting as immunoadjuvants. NPs induce production of free radicals (ROS), activate receptors (e.g., TLR-4) and improve transcription of pro-inflammatory genes with production of specific cytokines determining inflammation. Endosomal rupture releases antigen to the cytosol where the antigen starts to be processed to yield smaller peptides to be presented as such by the major histocompatibility complex (MHC) after transportation to the surface of the cell. Improving antigen release in the cytosol induces proliferation of antigen-specific T-cells sub-sets. Reproduced from [<a href="#B79-pharmaceutics-16-01362" class="html-bibr">79</a>].</p>
Full article ">Figure 3
<p>Virus-like particles (VLPs) and the immune system. In <b>step 1</b>, interaction with receptors on the dendritic cell (DC) and VLP uptake. In <b>step 2</b>, maturation of DC and release of cytokines such as TNF-α and IL-1β that are pro-inflammatory with recruitment of additional antigen presenting cells (APCs), including DC and macrophages. In <b>step 3</b>, enzymatic hydrolysis of VLP antigens into peptides with their binding to MHC I and MHC II for presentation at the DC surface. In <b>step 4</b>, peptide on MHC II, CD40 (in red) and CD80/86 (in blue) interact with T-cell receptor TCR, CD40L (in orange) and CD28 (in magenta) present on naïve helper T-cell (Th), respectively, followed by proliferation and differentiation of Th cells into type 1 (Th1) and type 2 (Th2) cells; in addition, peptides on MHC I of the DC, CD40 and CD80/86 also interact with TCR, CD40L, and CD28 present on the naïve cytotoxic T lymphocyte (CTL). On <b>step 5</b>, aided by Th1, naïve CTL proliferates and differentiates into effector and memory CTLs for cellular immunity. On <b>step 6</b>, naïve B cell interacts with VLP (from the blood stream) or DC via B cell receptor (BCR). With help of Th2, the B cell differentiation into plasma B cells occurs; the plasma B cells account for active release of antibodies in humoral immune response; in addition, differentiation into memory B cells also takes place, being responsible for the long-lasting antibody production. Reproduced from reference [<a href="#B121-pharmaceutics-16-01362" class="html-bibr">121</a>]. Copyright (2022), with permission from John Wiley and Sons.</p>
Full article ">Figure 4
<p>The amplification of L1 coding region of human papilloma virus (HPV) using recombinant DNA technology for production of prophylactic vaccines. One should notice that the self-assembly of the L1 recombinant protein generated the virus-like nanoparticle (HPV-VLP). Reprinted from reference [<a href="#B123-pharmaceutics-16-01362" class="html-bibr">123</a>].</p>
Full article ">Figure 5
<p>Cationic lipid nanoparticle mRNA vaccines applied to several infectious diseases. Reproduced from reference [<a href="#B128-pharmaceutics-16-01362" class="html-bibr">128</a>]. Copyright (2021), with permission from Elsevier.</p>
Full article ">Figure 6
<p>Viability of mammalian cell lines in the presence of cationic adjuvants based on the DODAB cationic lipid as reprinted from reference [<a href="#B16-pharmaceutics-16-01362" class="html-bibr">16</a>]. J774A.1 macrophages and L929 fibroblasts were exposed to adjuvants PMMA/DODAB (gray bars), DODAB BF (orange bars) or DODAB LV (blue bars) for 3 h (<b>a</b>,<b>c</b>) or 24 h (<b>b</b>,<b>d</b>). PMMA is the biocompatible polymer poly (methyl methacrylate). DODAB is the synthetic cationic lipid dioctadecyl dimethyl ammonium bromide, BF is bilayer fragment and LV is large vesicle. The highest cell viabilities in the presence of DODAB were obtained for the PMMA/DODAB adjuvant (gray bars) with a threshold concentration of 0.08 mM DODAB (red arrow).</p>
Full article ">Figure 7
<p>Dose-dependent cytotoxicity of cationic hybrid NPs made of biocompatible polymer and traces of cationic polymer and cationic lipid. (<b>A</b>) PMMA/PDDA/DODAB NPs visualized by scanning electron microscopy (SEM) and at 0.56 M methyl methacrylate (MMA) polymerization followed by exhaustive dialysis yielded 5 mg·mL<sup>−1</sup> PDDA and 2 mM DODAB followed by exhaustive dialysis before use; the bar represents 1000 nm. Reproduced from reference [<a href="#B66-pharmaceutics-16-01362" class="html-bibr">66</a>]. (<b>B</b>) Effect of poly diallyl dimethylammonium chloride (PDDA) concentration in hybrid NPs of biocompatible poly methyl methacrylate (PMMA) on L929 fibroblasts (<b>a</b>) or murine macrophages J774A.1 viability (%) after 3 or 24 h interaction (<b>b</b>). Reproduced from reference [<a href="#B15-pharmaceutics-16-01362" class="html-bibr">15</a>]. (<b>C</b>) PDDA dose-dependent lysis of fibroblasts in culture; the cells were submitted to increasing PDDA concentrations from (<b>a</b>) to (<b>d</b>) and are visualized by scanning electron microscopy (SEM) of fibroblasts L929 incubated for 3 h with: (<b>a</b>) culture medium; (<b>b</b>) 0.01; (<b>c</b>) 0.1; (<b>d</b>) 1 mg·mL<sup>−1</sup> PDDA; the red arrows point to holes on the cells at 0.1 mg·mL<sup>−1</sup> PDDA. Reproduced from [<a href="#B20-pharmaceutics-16-01362" class="html-bibr">20</a>].</p>
Full article ">Figure 8
<p>Thermostability of the vaccine conferred by the layer-by-layer cationic assembly of PEI-SiO<sub>2</sub>-PEI on Japanese encephalitis virus (JEV). (<b>A</b>) Scheme showing the coating of PEI and silica on the surface of the viral nanoparticles. The first coating with PEI (in magenta) is followed by the second coating with silica (in green) and the third coating with PEI (in magenta). (<b>B</b>) Zeta potential measurements of JEV and JEV coated with successive layers of PEI, PEI-SiO<sub>2</sub> and PEI-SiO<sub>2</sub>-PEI. (<b>C</b>) Evaluation of the vaccine’s stability after silicification at pH 7.0, demonstrating enhanced resistant to temperature fluctuations. The modified vaccine maintained its efficacy after prolonged storage at room temperature, enabling more flexible vaccine handling and distribution without the need for cold chain logistics. Adapted from [<a href="#B160-pharmaceutics-16-01362" class="html-bibr">160</a>].</p>
Full article ">Figure 9
<p>Proton sponge cationic nano-assembly (PSNA) as inducer of cancer cell death. (<b>A</b>) Chemical structure of PSNA monomer and its self-assembly into a fluorescent nanostructure. (<b>B</b>) Endocytosis of PSNAs by cancer cells triggering cell death and releasing pro-inflammatory cytokines (e.g., IL-1β) known to induce anticancer immunity. The dashed arrows represent suggestions of other possible mechanisms for the internalization of the nano-assembly and the cell. Reproduced from [<a href="#B189-pharmaceutics-16-01362" class="html-bibr">189</a>] with permission from John Wiley and Sons under a Creative Commons License.</p>
Full article ">Figure 10
<p>Cationic nanoparticles self-assembled from the sophisticated di-block copolymer construction shown on the left. Combining PEI moiety, antigen and poly-IC, this cancer nanovaccine was able to elicit cross-presentation and efficient CD8+ T cell proliferation. Reprinted from reference [<a href="#B197-pharmaceutics-16-01362" class="html-bibr">197</a>]. Copyright (2024), with permission from Elsevier.</p>
Full article ">
23 pages, 3409 KiB  
Article
3-O-Ethyl Ascorbic Acid and Cannabigerol in Modulating the Phospholipid Metabolism of Keratinocytes
by Iwona Jarocka-Karpowicz, Izabela Dobrzyńska, Anna Stasiewicz and Elżbieta Skrzydlewska
Antioxidants 2024, 13(11), 1285; https://doi.org/10.3390/antiox13111285 - 24 Oct 2024
Viewed by 731
Abstract
Phospholipids and their metabolites play an important role in maintaining the membrane integrity and the metabolic functions of keratinocytes under physiological conditions and in the regeneration process after exposure to high-energy UVB radiation. Therefore, in the search for compounds with a protective and [...] Read more.
Phospholipids and their metabolites play an important role in maintaining the membrane integrity and the metabolic functions of keratinocytes under physiological conditions and in the regeneration process after exposure to high-energy UVB radiation. Therefore, in the search for compounds with a protective and regenerative effect on keratinocyte phospholipids, the effectiveness of two antioxidant compounds has been tested: a stable derivative of ascorbic acid, 3-O-ethyl ascorbic acid (EAA) and cannabigerol (CBG), both of which are primarily located in the membrane structures of keratinocytes. In addition, this study has demonstrated that EAA and CBG, especially in a two-component combination, enhance the antioxidant properties of keratinocytes and reduce lipid peroxidation assessed at the level of MDA (malondialdehyde)/neuroprostanes. Moreover, by reducing the activity of enzymes that metabolise phospholipids, free PUFAs (polyunsaturated fatty acids) and endocannabinoids (PLA2; phospholipase A2, COX1/2; cyclooxygenases 1/2, LOX-5; lipoxygenase 5, FAAH; fatty acid amide hydrolase, MAGL; monoacylglycerol lipase), antioxidants have been found to regulate the levels of endocannabinoids (AEA; anandamide, 2-AG; 2-arachidonoylglycerol, PEA; palmitoylethanolamide) and eicosanoids (PGD2; prostaglandin D2, PGE2; prostaglandin E2, 15-d-PGJ2; 15-deoxy-Δ12,14-prostaglandin J2, 15-HETE; 15-hydroxyeicosatetraenoic acid), that are enhanced by UVB radiation. The metabolic effect of both groups of PUFA metabolites is mainly related to the activation of G protein-related receptors (CB1/2; cannabinoid receptor 1 and 2, PPARγ; peroxisome proliferator-activated receptor gamma, TRPV1; transient receptor potential cation channel subfamily V member 1), the expression of which is reduced under the influence of EAA, CBG, and especially the two-component combination. It promotes the regeneration of keratinocyte metabolism disrupted by UVB, particularly in relation to redox balance and inflammation. Full article
(This article belongs to the Section Natural and Synthetic Antioxidants)
Show Figures

Figure 1

Figure 1
<p>Percentage content of EAA or/and CBG in the cytosol and membrane fraction on the following groups of keratinocytes cultured for 24 h with EAA (150 µM) or/and CBG (1 µM), as well as cells exposed to UVB radiation (60 mJ/cm<sup>2</sup>) and then cultured for 24 h with EAA (150 µM) or/and CBG (1 µM). The mean ± SD values (n = 5) are presented with statistically significant differences: in cytosol or membrane a—vs. EAA (or CBG); b—vs. UVB + EAA (or UVB + CBG); c—vs. EAA + CBG (or CBG + EAA); <span class="html-italic">p</span> ≤ 0.05 formatting.</p>
Full article ">Figure 2
<p>The effect of EAA or/and CBG on total antioxidant status (TAS) in the following groups of keratinocytes: control; cultured for 24 h with EAA (150 µM) or/and CBG (1 µM); as well as cells exposed to UVB radiation (60 mJ/cm<sup>2</sup>) and then cultured for 24 h with EAA (150 µM) or/and CBG (1 µM). The mean ± SD values (n = 5) are presented with statistically significant differences: a—vs. control group; b—vs. EAA group; c—vs. CBG group; x—vs. UVB radiation group; y—vs. UVB + EAA group; z–vs. UVB + CBG group; <span class="html-italic">p</span> ≤ 0.05.</p>
Full article ">Figure 3
<p>The effect of EAA or/and CBG on the level of (<b>A</b>) phospholipid (PL) and (<b>B</b>) free non-saturated fatty acids in the following groups of keratinocytes: control; cultured for 24 h with EAA (150 µM) or/and CBG (1 µM); as well as cells exposed to UVB radiation (60 mJ/cm<sup>2</sup>) and then cultured for 24 h with EAA (150 µM) or/and CBG (1 µM). The mean ± SD values (n = 5) are presented with statistically significant differences: a—vs. control group; b—vs. EAA group; c—vs. CBG group; x—vs. UVB radiation group; y—vs. UVB + EAA group; z—vs. UVB + CBG group; <span class="html-italic">p</span> ≤ 0.05.</p>
Full article ">Figure 4
<p>The effect of EAA or/and CBG on the level of sialic acid and zeta potential in the following groups of keratinocytes: control; cultured for 24 h with EAA (150 µM) or/and CBG (1 µM); as well as cells exposed to UVB radiation (60 mJ/cm<sup>2</sup>) and then cultured for 24 h with EAA (150 µM) or/and CBG (1 µM). The mean ± SD values (n = 5) are presented with statistically significant differences: a—vs. control group; x—vs. UVB radiation group; <span class="html-italic">p</span> ≤ 0.05.</p>
Full article ">Figure 5
<p>The effect of CBG or/and EAA on the level of lipid peroxidation products, malondialdehyde (MDA), and F4t-neuroprostane (NPs) in the following groups of keratinocytes: control; cultured for 24 h with EAA (150 µM) or/and CBG (1 µM); as well as cells exposed to UVB radiation (60 mJ/cm<sup>2</sup>) and then cultured for 24 h with EAA (150 µM) or/and CBG (1 µM). The mean ± SD values (n = 5) are presented with statistically significant differences: a—vs. control group; b—vs. EAA group; x—vs. UVB radiation group; y—vs. UVB + EAA group; z—vs. UVB + CBG group; <span class="html-italic">p</span> ≤ 0.05.</p>
Full article ">Figure 6
<p>The activity of enzymes involved in the metabolism of eicosanoids cPLA2, COX1/2, and LOX-5 in the following groups of keratinocytes: control; cultured for 24 h with EAA (150 µM) or/and CBG (1 µM); as well as cells exposed to UVB radiation (60 mJ/cm<sup>2</sup>) and then cultured for 24 h with EAA (150 µM) or/and CBG (1 µM). The mean ± SD values (n = 5) are presented with statistically significant differences: a—vs. control group; b—vs. EAA group; c—vs. CBG group; x—vs. UVB radiation group; y—vs. UVB + EAA group; z—vs. UVB + CBG group; <span class="html-italic">p</span> ≤ 0.05.</p>
Full article ">Figure 7
<p>Level of (<b>A</b>) pro-inflammatory eicosanoids PGD2 and PGE2 and (<b>B</b>) anti-inflammatory eicosanoids 15-d-PGJ2 and 15-HETE in the following groups of keratinocytes: control; cultured for 24 h with EAA (150 µM) or/and CBG (1 µM); as well as cells exposed to UVB radiation (60 mJ/cm<sup>2</sup>) and then cultured for 24 h with EAA (150 µM) or/and CBG (1 µM). The mean ± SD values (n = 5) are presented with statistically significant differences: a—vs. control group; b—vs. EAA group; c—vs. CBG group; x—vs. UVB radiation group; y—vs. UVB + EAA group; z—vs. UVB + CBG group; <span class="html-italic">p</span> ≤ 0.05.</p>
Full article ">Figure 8
<p>The changes in the endocannabinoid system measured as the level of endocannabinoids (AEA, 2-AG, PEA) and activity of their degrading enzymes (FAAH and MAGL) in the following groups of keratinocytes: control; cultured for 24 h with EAA (150 µM) or/and CBG (1 µM); as well as cells exposed to UVB radiation (60 mJ/cm<sup>2</sup>) and then cultured for 24 h with EAA (150 µM) or/and CBG (1 µM). The mean ± SD values (n = 5) are presented with statistically significant differences: a—vs. control group; b—vs. EAA group; c—vs. CBG group; x—vs. UVB radiation group; y—vs. UVB + EAA group; z—vs. UVB + CBG group; <span class="html-italic">p</span> ≤ 0.05.</p>
Full article ">Figure 9
<p>The level of membrane receptors activated by lipid mediators: CB1, CB2, PPARγ, and TRPV1 in the following groups of keratinocytes: control; cultured for 24 h with EAA (150 µM) or/and CBG (1 µM); as well as cells exposed to UVB radiation (60 mJ/cm<sup>2</sup>) and then cultured for 24 h with EAA (150 µM) or/and CBG (1 µM). The mean ± SD values (n = 5) are presented with statistically significant differences: a—vs. control group; b—vs. EAA group; c—vs. CBG group; x—vs. UVB radiation group; y—vs. UVB + EAA group; z—vs. UVB + CBG group; <span class="html-italic">p</span> ≤ 0.05.</p>
Full article ">
13 pages, 840 KiB  
Article
Assessment of the Antioxidative Properties of Extracts from the Fruits of Pyrus pyraster (L.) Burgsd and Pyrus ×myloslavensis Czarna & Antkowiak Grown under Natural Environmental Conditions
by Marzanna Hęś, Wojciech Antkowiak, Kinga Stuper-Szablewska, Krzysztof Dziedzic, Marta Jessa and Paulina Ratajczak
Agriculture 2024, 14(10), 1790; https://doi.org/10.3390/agriculture14101790 - 12 Oct 2024
Viewed by 504
Abstract
Analyses were conducted on extracts from the fruits of P. pyraster and P. ×myloslavensis. Extraction with 80% methanol was performed at room temperature. The total phenolic content was determined by spectrophotometry using the Folin–Ciocalteu reagent, with gallic acid as the reference [...] Read more.
Analyses were conducted on extracts from the fruits of P. pyraster and P. ×myloslavensis. Extraction with 80% methanol was performed at room temperature. The total phenolic content was determined by spectrophotometry using the Folin–Ciocalteu reagent, with gallic acid as the reference standard. Phenolic compounds and organic acids were identified on a liquid chromatograph. The antioxidative activity of the extracts was tested in relation to linoleic acid incubation of the emulsions for 19 h based on the neutralization of the DPPH radical (2,2-diphenyl-1-picrylhydrazyl) and the ABTS cation radical (2,2′-azino-bis[3-ethylbenzothiazoline-6-sulfonic acid]) as well as by the ferric reducing antioxidant power (FRAP) assay. The analyses showed that the extract from P. pyraster fruits is characterized by a higher content of phenolic compounds and a higher antioxidative potential compared with that from P. ×myloslavensis. In extracts of both pear species, seven phenolic compounds and four organic acids were identified. The total fiber content in pears of P. pyraster and P. ×myloslavensis was determined at 36.45 g and 24.74 g/100 g d.m. of the pear fruits, of which most comprised the insoluble fraction (32.49 g and 20.86/100 g, respectively). The results of the conducted research are highly significant, as they confirm that pears contain many valuable nutrients and biologically active compounds, including antioxidants and dietary fiber. Adding pear extracts to food products may offer a way to boost their health benefits while also broadening the variety of items that have appealing sensory characteristics. Moreover, research has shown that fruit extracts can help to prolong the shelf life of food products by safeguarding them against lipid oxidation and the decline in their nutritional value. Full article
Show Figures

Figure 1

Figure 1
<p>Correlation between the total phenolic content of <span class="html-italic">P. pyraster</span> and <span class="html-italic">P.</span> ×<span class="html-italic">myloslavensis</span> fruit extracts (mg GAE/g d.m.) (X-axis) and (<b>a</b>) DPPH, (<b>b</b>) the ABTS radical scavenging activity (mg Trolox/g s.m.), and (<b>c</b>) the FRAP reducing potential (mM Fe<sup>2+</sup>) (Y-axis).</p>
Full article ">
13 pages, 2866 KiB  
Article
Comparative Properties of Helical and Linear Amphipathicity of Peptides Composed of Arginine, Tryptophan, and Valine
by Jessie Klousnitzer, Wenyu Xiang, Vania M. Polynice and Berthony Deslouches
Antibiotics 2024, 13(10), 954; https://doi.org/10.3390/antibiotics13100954 - 11 Oct 2024
Viewed by 964
Abstract
Background: The persistence of antibiotic resistance has incited a strong interest in the discovery of agents with novel antimicrobial mechanisms. The direct killing of multidrug-resistant bacteria by cationic antimicrobial peptides (AMPs) underscores their importance in the fight against infections associated with antibiotic resistance. [...] Read more.
Background: The persistence of antibiotic resistance has incited a strong interest in the discovery of agents with novel antimicrobial mechanisms. The direct killing of multidrug-resistant bacteria by cationic antimicrobial peptides (AMPs) underscores their importance in the fight against infections associated with antibiotic resistance. Despite a vast body of AMP literature demonstrating a plurality in structural classes, AMP engineering has been largely skewed toward peptides with idealized amphipathic helices (H-amphipathic). In contrast to helical amphipathicity, we designed a series of peptides that display the amphipathic motifs in the primary structure. We previously developed a rational framework for designing AMP libraries of H-amphipathic peptides consisting of Arg, Trp, and Val (H-RWV, with a confirmed helicity up to 88% in the presence of membrane lipids) tested against the most common MDR organisms. Methods: In this study, we re-engineered one of the series of the H-RWV peptides (8, 10, 12, 14, and 16 residues in length) to display the amphipathicity in the primary structure by side-by-side (linear) alignment of the cationic and hydrophobic residues into the 2 separate linear amphipathic (L-amphipathic) motifs. We compared the 2 series of peptides for antibacterial activity, red blood cell (RBC) lysis, killing and membrane-perturbation properties. Results: The L-RWV peptides achieved the highest antibacterial activity at a minimum length of 12 residues (L-RWV12, minimum optimal length or MOL) with the lowest mean MIC of 3–4 µM, whereas the MOL for the H-RWV series was reached at 16 residues (H-RWV16). Overall, H-RWV16 displayed the lowest mean MIC at 2 µM but higher levels of RBC lysis (25–30%), while the L-RWV series displayed minor RBC lytic effects at the test concentrations. Interestingly, when the S. aureus strain SA719 was chosen because of its susceptibility to most of the peptides, none of the L-RWV peptides demonstrated a high level of membrane perturbation determined by propidium iodide incorporation measured by flow cytometry, with <50% PI incorporation for the L-RWV peptides. By contrast, most H-RWV peptides displayed almost up to 100% PI incorporation. The results suggest that membrane perturbation is not the primary killing mechanism of the L-amphipathic RWV peptides, in contrast to the H-RWV peptides. Conclusions: Taken together, the data indicate that both types of amphipathicity may provide different ideal pharmacological properties that deserve further investigation. Full article
Show Figures

Figure 1

Figure 1
<p>Comparative properties of H-RWV12 and L-RWV12. The primary sequence of the peptide H-WRV12 (left, (<b>A</b>)) consists of interspersed (scrambled) cationic (R, Arg) and hydrophobic (H) residues (W or V), and it is predicted to form an idealized amphipathic helix as indicated by the helical wheel diagram and high hydrophobic moment (µH, 0.87). By contrast, the primary sequence of L-RWV12, with identical amino acid composition to that of H-RWV12, displays the amphipathicity in the primary structure with C and H motifs held by peptide bonds or covalence, although its secondary structure appears scrambled to helicity with a much lower helical amphipathicity (µH, 0.197; (<b>A</b>), right helical wheel). Notably, L-RWV12 is not a negative control of H-RWV12, functionally; it is rather the more active form of the 2 RWV peptides against <span class="html-italic">S. haemolyticus</span> (SH 730, (<b>B</b>)). Test medium: physiologically relevant RFM (60% RPMI plus 10% fetal bovine serum or FBS and 30% MHB2); endogenous AMPs: IND26, indolicidin and Ttrp27, tritrpticin; MIC, minimum inhibitory concentration; data are representative of 2 independent trials with identical results.</p>
Full article ">Figure 2
<p>Comparative antibacterial activities of the H-RWV and L-RWV series. The 2 series were compared against MDR strains of 6 organisms as indicated. The test medium was composed of physiologically relevant RFM (60% RPMI plus 10% fetal bovine serum or FBS and 30% cation-adjusted MHB); endogenous AMP control was Indolicidin (Indo); small-molecule antibiotic controls were cefazolin, ceftazidime (Ceft), and meropenem (Mero). MIC, minimum inhibitory concentration with means represented by the black and red horizontal bars, which are used to determine the MOLs (minimum optimal lengths) indicated by the red and black arrows. (<b>A</b>–<b>F</b>) is based on the test organism as indicated. Data are representative of 2 independent trials. Corresponding <a href="#antibiotics-13-00954-t002" class="html-table">Table 2</a> provides the mean MICs for the strains of each organism. The numbers stand for each peptide: 8, L/H-RWV8; 10, L/H-RWV10, etc.; red bar, mean MIC of L-RWV peptides and black bars, mean MIC of H-RWV peptides.</p>
Full article ">Figure 3
<p>Antibiofilm activities of the R- and L-RWV peptides. MBEC or minimum biofilm elimination concentration is the minimum concentration at which no biomass was detected by the crystal violet method. Standard deviations reflect differences between 2 independent trials. The dashed line is to clarify the mid-point between 0 and 5.</p>
Full article ">Figure 4
<p>Human RBC lytic effects of the R- and L-RWV peptides. Indolicidin (Indo) was used as control; RBC lysis was assayed in PBS as described in Methods. For clarity, the dashed line indicates the 10% lysis mark across the graph as a critical point between minor (&lt;10%) and moderate (&gt;10%) RBC lysis.</p>
Full article ">Figure 5
<p>Killing kinetics of the R- and L-RWV peptides. The strain SA719, which is susceptible to most of the peptides, was used for time-dependent killing. Data are representative of 2 independent trials.</p>
Full article ">Figure 6
<p>PI incorporation of RWV peptides. LRWV and H-RWV peptides from 12 to 16 residues in length were used to assess the comparative membrane-perturbing effects of the 2 series using the clinical isolate SA719. EtOH, ethanol (50%) was used as positive control and oxacillin (oxa) as negative control; unTx, untreated (0 µM); data are representative of 2 independent trials.</p>
Full article ">
20 pages, 909 KiB  
Review
Role of Na+-K+ ATPase Alterations in the Development of Heart Failure
by Naranjan S. Dhalla, Vijayan Elimban and Adriana Duris Adameova
Int. J. Mol. Sci. 2024, 25(19), 10807; https://doi.org/10.3390/ijms251910807 - 8 Oct 2024
Viewed by 1367
Abstract
Na+-K+ ATPase is an integral component of cardiac sarcolemma and consists of three major subunits, namely the α-subunit with three isoforms (α1, α2, and α3), β-subunit with two isoforms (β1 and β2 [...] Read more.
Na+-K+ ATPase is an integral component of cardiac sarcolemma and consists of three major subunits, namely the α-subunit with three isoforms (α1, α2, and α3), β-subunit with two isoforms (β1 and β2) and γ-subunit (phospholemman). This enzyme has been demonstrated to transport three Na and two K ions to generate a trans-membrane gradient, maintain cation homeostasis in cardiomyocytes and participate in regulating contractile force development. Na+-K+ ATPase serves as a receptor for both exogenous and endogenous cardiotonic glycosides and steroids, and a signal transducer for modifying myocardial metabolism as well as cellular survival and death. In addition, Na+-K+ ATPase is regulated by different hormones through the phosphorylation/dephosphorylation of phospholemman, which is tightly bound to this enzyme. The activity of Na+-K+ ATPase has been reported to be increased, unaltered and depressed in failing hearts depending upon the type and stage of heart failure as well as the association/disassociation of phospholemman and binding with endogenous cardiotonic steroids, namely endogenous ouabain and marinobufagenin. Increased Na+-K+ ATPase activity in association with a depressed level of intracellular Na+ in failing hearts is considered to decrease intracellular Ca2+ and serve as an adaptive mechanism for maintaining cardiac function. The slight to moderate depression of Na+-K+ ATPase by cardiac glycosides in association with an increased level of Na+ in cardiomyocytes is known to produce beneficial effects in failing hearts. On the other hand, markedly reduced Na+-K+ ATPase activity associated with an increased level of intracellular Na+ in failing hearts has been demonstrated to result in an intracellular Ca2+ overload, the occurrence of cardiac arrhythmias and depression in cardiac function during the development of heart failure. Furthermore, the status of Na+-K+ ATPase activity in heart failure is determined by changes in isoform subunits of the enzyme, the development of oxidative stress, intracellular Ca2+-overload, protease activation, the activity of inflammatory cytokines and sarcolemmal lipid composition. Evidence has been presented to show that marked alterations in myocardial cations cannot be explained exclusively on the basis of sarcolemma alterations, as other Ca2+ channels, cation transporters and exchangers may be involved in this event. A marked reduction in Na+-K+ ATPase activity due to a shift in its isoform subunits in association with intracellular Ca2+-overload, cardiac energy depletion, increased membrane permeability, Ca2+-handling abnormalities and damage to myocardial ultrastructure appear to be involved in the progression of heart failure. Full article
(This article belongs to the Special Issue The Na, K-ATPase in Health and Disease)
Show Figures

Figure 1

Figure 1
<p>Role of alterations in Na<sup>+</sup>-K<sup>+</sup> ATPase isozymes and depression in the enzyme activity in the development of heart failure. ↑—increase.</p>
Full article ">Figure 2
<p>Role of changes in signal transduction mechanisms following depression of Na<sup>+</sup>-K<sup>+</sup> ATPase activity in the progression of heart failure. ↑—increase.</p>
Full article ">Figure 3
<p>Role of various hormones in the depression Na<sup>+</sup>-K<sup>+</sup> ATPase activity and changes in cardiac cation contents in the development of heart failure. ↑—increase.</p>
Full article ">
19 pages, 3026 KiB  
Article
Stable Polymer-Lipid Hybrid Nanoparticles Based on mcl-Polyhydroxyalkanoate and Cationic Liposomes for mRNA Delivery
by Sergey M. Shishlyannikov, Ilya N. Zubkov, Vera V. Vysochinskaya, Nina V. Gavrilova, Olga A. Dobrovolskaya, Ekaterina A. Elpaeva, Mikhail A. Maslov and Andrey Vasin
Pharmaceutics 2024, 16(10), 1305; https://doi.org/10.3390/pharmaceutics16101305 - 7 Oct 2024
Viewed by 1296
Abstract
Background/Objectives: The development of polymer–lipid hybrid nanoparticles (PLNs) is a promising area of research, as it can help increase the stability of cationic lipid carriers. Hybrid PLNs are core–shell nanoparticle structures that combine the advantages of both polymer nanoparticles and liposomes, especially in [...] Read more.
Background/Objectives: The development of polymer–lipid hybrid nanoparticles (PLNs) is a promising area of research, as it can help increase the stability of cationic lipid carriers. Hybrid PLNs are core–shell nanoparticle structures that combine the advantages of both polymer nanoparticles and liposomes, especially in terms of their physical stability and biocompatibility. Natural polymers such as polyhydroxyalkanoate (PHA) can be used as a matrix for the PLNs’ preparation. Methods: In this study, we first obtained stable cationic hybrid PLNs using a cationic liposome (CL) composed of a polycationic lipid 2X3 (1,26-bis(cholest-5-en-3β-yloxycarbonylamino)-7,11,16,20-tetraazahexacosane tetrahydrochloride), helper lipid DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine), and the hydrophobic polymer mcl-PHA, which was produced by the soil bacterium Pseudomonas helmantisensis P1. Results: The new polymer-lipid carriers effectively encapsulated and delivered model mRNA-eGFP (enhanced green fluorescent protein mRNA) to BHK-21 cells. We then evaluated the role of mcl-PHA in increasing the stability of cationic PLNs in ionic solutions using dynamic light scattering data, electrophoretic mobility, and transmission electron microscopy techniques. Conclusions: The results showed that increasing the concentration of PBS (phosphate buffered saline) led to a decrease in the stability of the CLs. At high concentrations of PBS, the CLs aggregate. In contrast, the presence of isotonic PBS did not result in the aggregation of PLNs, and the particles remained stable for 120 h when stored at +4 °C. The obtained results show that PLNs hold promise for further in vivo studies on nucleic acid delivery. Full article
(This article belongs to the Special Issue Polymer-Based Delivery System)
Show Figures

Figure 1

Figure 1
<p>Reactor for the synthesis of PLNs. Reaction tube and the sonicator probe are placed in a beaker with water. During the synthesis and under sonication, the organic solvent (<span class="html-italic">n</span>-hexane) is removed by evaporation in argon stream.</p>
Full article ">Figure 2
<p>Analysis of mRNA binding with PLNs by capillary electrophoresis. Control RNA—control mRNA samples without PLNs containing 50 ng of mRNA. PHA-2X3—complexes of mRNA with PLNs stabilized by 2X3; PHA-2X3-DOPE 1:1—complexes of mRNA with PLNs stabilized by a mixture of 2X3 and DOPE in a molar ratio of 1:1; PHA-2X3-DOPE 1:2—complexes of mRNA with PLNs stabilized with a mixture of 2X3 and DOPE in a molar ratio of 1:2. PHA-2X3-DOPE 1:3—complexes of mRNA with PLNs stabilized with a mixture of 2X3 and DOPE in a molar ratio of 1:3. PHA/lipids ratio in all the PLNs was 20:1 (wt.). Green line—signal of the fluorescent dye (used as an internal control for the electrophoresis). N/P — molar ratio between positively charged cationic liposomes and negatively charged delivered mRNA molecules.</p>
Full article ">Figure 3
<p>The efficiency of mRNA-eGFP delivery using CLs and PLNs in BHK-21 cells was measured using flow cytometry. The transfected cells were analyzed for the percentage of cells with detectable eGFP signals, and the MFI (mean fluorescence intensity) was recorded. Lipofectamine MessengerMAX (Lipofectamine MM) is a commercial transfection reagent and was used as a positive control for mRNA transfection. All the measurements were triplicated. The statistical analysis was performed using a two-way ANOVA: **—<span class="html-italic">p</span> &lt; 0.01; not significant—‘ns’.</p>
Full article ">Figure 4
<p>Dependences of the average particle diameter (d, nm), polydispersity (PDI), and ζ-potential (ζ, mV) on the N/P. Complexes of the PLNs (PHA-2X3-DOPE 1:3) and mRNA-eGFP were analyzed. PLNs (PHA-2X3-DOPE 1:3) were used as a control.</p>
Full article ">Figure 5
<p>(<b>a</b>) Efficiency of mRNA-Cy5 uptake with PLNs and CLs by BHK-21 cells determined by flow cytometry. Transfected cells—the percentage of fluorescent cells (Cy5 signal); MFI—mean fluorescence intensity. Statistical analysis was performed using one-way ANOVA: ***—<span class="html-italic">p</span> &lt; 0.001; **—<span class="html-italic">p</span> &lt; 0.01. (<b>b</b>) Fluorescence microscopy of cells transfected with mRNA-Cy5 mRNA complexes using PHA-2X3-DOPE 1:3, 2X3-DOPE 1:3, and Lipofectamine Messenger MAX (Lipofectamine MM); Scale bar 50 μm; cell nuclei–blue, eGFP—green, and mRNA–Cy5—red.</p>
Full article ">Figure 6
<p>Dependences of the average particle diameter (d, nm), polydispersity (PDI) and ζ-potential (ζ, mV) on the molar concentration of Na<sup>+</sup> in PBS. PLNs (PHA-2X3-DOPE 1:3) or CLs (2X3-DOPE 1:3) were mixed with PBS and incubated for either 2 h at 25 °C or 5 days at 4 °C.</p>
Full article ">Figure 7
<p>Transmission electron microscopy of PLNs (PHA-2X3-DOPE 1:3) and CLs (2X3-DOPE 1:3) at various Na<sup>+</sup> concentrations (0, 30, and 150 mM; incubation time 2 h). Scale bar: 150 nm (<b>A,B</b>), 100 nm (<b>C,E</b>), 200 nm (<b>D</b>), 500 nm (<b>F</b>).</p>
Full article ">
Back to TopTop